|Articles|April 22, 2011
Enzymotec Signs Krill Deal with India Pharma Company
Enzymotec Ltd. has signed a long term deal to supply krill oil to Lupin Ltd. (Mumbai, India), a leading pharmaceutical company focusing on non-steroidal anti-inflammatory drugs, bacterial infections, and cardiovascular disease.
Advertisement
Enzymotec Ltd. (Migdal HaEmek, Israel) has signed a long term deal to supply krill oil to Lupin Ltd. (Mumbai, India), a leading pharmaceutical company focusing on non-steroidal anti-inflammatory drugs, bacterial infections, and cardiovascular disease.
Lupin is the world’s fifth largest pharmaceutical company, based on subscriptions, says Enzymotec.
A Krill Oil+ product will launch later this year in Indian markets.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Nutritional Outlook - Supplement, Food & Beverage Manufacturing Trends
1
New Report Calls for Combined Sodium-Potassium Strategy in Hypertension Management
2
Ross Introduces 250-Gallon Retention Mixers for High-Pressure Processing
3
RFI Ingredients Takes On Minority Investment From Astanor to Fund Global Expansion
4
Collagen Sourcing and Production Methods for Finished Product Manufacturers
5